Anixa Biosciences, Inc. (ANIX) vs ImmuCell Corporation (ICCC)

A side-by-side comparison of Anixa Biosciences, Inc. and ImmuCell Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Anixa Biosciences, Inc. logo
ANIX
Anixa Biosciences, Inc.
$103M
$3.03HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
ImmuCell Corporation logo
ICCC
ImmuCell Corporation
$89M
$9.80HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT

Total return — ANIX vs ICCC

growth of $100 · dividends reinvested · last 10y
ANIX -47.3% (-6.2%/yr)ICCC +25.3% (+2.3%/yr)ICCC compounded faster over this window
50100150Start $10020182020202220242026$53$125
ANIX ICCC

ANIX vs ICCC: by the numbers

  • •ANIX is the larger company ($103M vs $89M market cap).
  • •ICCC is profitable (2.57% net margin) while ANIX runs a net loss (0.00%).

Metrics side by side

Valuation

MetricANIXICCC
P/E ratioN/A115.84
P/S ratioN/A2.89
P/B ratio7.112.83
EV / EBITDAN/A14.76
FCF yieldN/A4.75%

Profitability

MetricANIXICCC
Gross margin0.00%40.32%
Operating margin0.00%12.60%
Net margin0.00%2.57%
ROE-72.02%2.51%
ROIC-82.35%8.16%

Growth (annualized)

MetricANIXICCC
Revenue CAGR (5Y)N/A13.74%
Total return CAGR (5Y)-8.26%0.65%

Frequently asked

Is ANIX or ICCC more profitable?
ICCC runs the higher net margin — ANIX at 0.00% versus ICCC at 2.57%.
How have ANIX and ICCC total returns compared?
Over the past 10 years, ANIX delivered -4.65% and ICCC delivered 2.46% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ANIX analysisFull ICCC analysisInteractive comparison tool

Dig into the metrics

ImmuCell P/E ratioAnixa Biosciences ROEImmuCell ROEAnixa Biosciences operating marginImmuCell operating marginAnixa Biosciences revenue growthImmuCell revenue growthAnixa Biosciences free cash flowImmuCell free cash flow

Anixa Biosciences & ImmuCell appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.